The aim of this study was to develop a highly sensitive human papillomavirus type 31 (HPV31) neutralization assay based on the production of pseudovirions carrying luciferase. Neutralizing antibodies against HPV31 were investigated in a set of HPV31 monoclonal antibodies and in women with evidence of HPV31 infection. Neutralizing antibodies were detected in 78% of subjects with a positive enzyme-linked immunosorbent assay
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
BACKGROUND: Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-li...
Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervic...
AbstractThe development of vaccines against human papillomaviruses (HPVs) has long been hampered by ...
AbstractSensitive high-throughput neutralization assays, based upon pseudoviruses carrying a secrete...
The majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific and hav...
BACKGROUND: Serology for human papillomaviruses (HPV) types -16 and -18 is established as an importa...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
AbstractWe show that minor capsid protein L2 is full length in clinical virion isolates and prepare ...
The aim of this study was to characterize the conformational neutralizing epitopes of the major caps...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
The papilloma- and polyomaviruses are small DNA viruses that infect humans. Some members of these vi...
We developed and validated a high-throughput human papillomavirus (HPV) serology method based on Lum...
Human papillomavirus (HPV) L1 virus-like particles (VLPs) were proven an effective vaccine candidate...
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
BACKGROUND: Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-li...
Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervic...
AbstractThe development of vaccines against human papillomaviruses (HPVs) has long been hampered by ...
AbstractSensitive high-throughput neutralization assays, based upon pseudoviruses carrying a secrete...
The majority of the neutralizing epitopes of papillomaviruses (PV) are conformation-specific and hav...
BACKGROUND: Serology for human papillomaviruses (HPV) types -16 and -18 is established as an importa...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
AbstractWe show that minor capsid protein L2 is full length in clinical virion isolates and prepare ...
The aim of this study was to characterize the conformational neutralizing epitopes of the major caps...
A highly sensitive, automated, purely add-on, high-throughput pseudovirion-based neutralization assa...
The papilloma- and polyomaviruses are small DNA viruses that infect humans. Some members of these vi...
We developed and validated a high-throughput human papillomavirus (HPV) serology method based on Lum...
Human papillomavirus (HPV) L1 virus-like particles (VLPs) were proven an effective vaccine candidate...
HPV prophylactic vaccination based on VLPs was implemented 7 years ago and has now shown a high degr...
BACKGROUND: Current vaccines against HPVs are constituted of L1 protein self-assembled into virus-li...
Neutralization of human papillomavirus type 11 (HPV-11) has been demonstrated using serum and cervic...